lifestyle.ebusinessplanet.com

Author: Deerfield Group

K36 Therapeutics announces presentation of First-in-Human Clinical Data for Gintemetostat (KTX-1001) Demonstrating Target Engagement and Clinical Activity in Multiple Myeloma at ASH 2025 and the Appointment of Dr. Shinta Cheng, M.D., Ph.D., as Chief Medical Officer

December 6, 2025
Alpha-9 Oncology Announces First Patient Dosed in Phase 1 Study of A9-3408 for the Treatment of Melanoma

December 5, 2025
Replicate Bioscience and Instituto Butantan Enter Collaborative Agreement to Develop and Commercialize Replicate’s Self-Replicating RNA (srRNA) Rabies Vaccine in Latin America

December 5, 2025
Magnet Biomedicine Appoints Bharat Reddy, Ph.D., as Chief Business Officer

November 6, 2025
Marengo to Present Late-Breaking Clinical Oral Abstract at SITC 2025 Highlighting Initial Monotherapy Activity of Invikafusp Alfa in Tissue-Agnostic, TMB-High Advanced Cancers

November 2, 2025
The T1D Fund Launches Bold New Capital Raise to Accelerate the Next Wave of Type 1 Diabetes Treatments, Prevention & Cures

November 1, 2025
Hemab Therapeutics Announces $157 Million Series C Financing to Advance Next-Generation Treatments for Underserved Bleeding Disorders

October 27, 2025
Accent Therapeutics Presents New Preclinical Data on Lead Clinical Programs ATX-295 and ATX-559 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

October 23, 2025
KLAS Recognizes AmplifyMD as a 2025 Top 20 Emerging Solution

October 23, 2025